A Parallel Reaction Monitoring Mass Spectrometric Method for Analysis of Potential CSF Biomarkers for Alzheimer's Disease
出版年份 2017 全文链接
标题
A Parallel Reaction Monitoring Mass Spectrometric Method for Analysis of Potential CSF Biomarkers for Alzheimer's Disease
作者
关键词
-
出版物
Proteomics Clinical Applications
Volume 12, Issue 1, Pages 1700131
出版商
Wiley
发表日期
2017-10-13
DOI
10.1002/prca.201700131
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Expanding the cerebrospinal fluid endopeptidome
- (2017) Karl T. Hansson et al. PROTEOMICS
- Reduced Levels of Amyloid-β-Binding Proteins in Cerebrospinal Fluid from Alzheimer's Disease Patients
- (2017) Sara F. Hansson et al. JOURNAL OF ALZHEIMERS DISEASE
- Cystatin C Protects Neuronal Cells from Amyloid-β-induced Toxicity
- (2017) Belen Tizon et al. JOURNAL OF ALZHEIMERS DISEASE
- Amyloid-β Oligomers Interact with Neurexin and Diminish Neurexin-mediated Excitatory Presynaptic Organization
- (2017) Yusuke Naito et al. Scientific Reports
- Cystatin C in aging and in Alzheimer’s disease
- (2016) Paul M. Mathews et al. AGEING RESEARCH REVIEWS
- β-amyloid increases neurocan expression through regulating Sox9 in astrocytes: A potential relationship between Sox9 and chondroitin sulfate proteoglycans in Alzheimer's disease
- (2016) Han Yan et al. BRAIN RESEARCH
- Tau Protein Quantification in Human Cerebrospinal Fluid by Targeted Mass Spectrometry at High Sequence Coverage Provides Insights into Its Primary Structure Heterogeneity
- (2016) Nicolas R Barthélemy et al. JOURNAL OF PROTEOME RESEARCH
- Alzheimer's disease
- (2016) Philip Scheltens et al. LANCET
- CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis
- (2016) Bob Olsson et al. LANCET NEUROLOGY
- Targeting LAMP2 in human cerebrospinal fluid with a combination of immunopurification and high resolution parallel reaction monitoring mass spectrometry
- (2016) Simon Sjödin et al. Clinical Proteomics
- Cystatin C Shifts APP Processing from Amyloid-β Production towards Non-Amyloidgenic Pathway in Brain Endothelial Cells
- (2016) Xia-Fei Wang et al. PLoS One
- Cerebrospinal fluid levels of the synaptic protein neurogranin correlates with cognitive decline in prodromal Alzheimer's disease
- (2015) Hlin Kvartsberg et al. Alzheimers & Dementia
- Explorative and targeted neuroproteomics in Alzheimer's disease
- (2015) Ann Brinkmalm et al. BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS
- Neuronal Pentraxin 1 Negatively Regulates Excitatory Synapse Density and Synaptic Plasticity
- (2015) J. Figueiro-Silva et al. JOURNAL OF NEUROSCIENCE
- Protective properties of lysozyme on β-amyloid pathology: implications for Alzheimer disease
- (2015) Linda Helmfors et al. NEUROBIOLOGY OF DISEASE
- High Resolution Discovery Proteomics Reveals Candidate Disease Progression Markers of Alzheimer’s Disease in Human Cerebrospinal Fluid
- (2015) Ronald C. Hendrickson et al. PLoS One
- Quantitative isoform-profiling of highly diversified recognition molecules
- (2015) Dietmar Schreiner et al. eLife
- Beta2-Microglobulin as a Diagnostic Marker in Cerebrospinal Fluid: A Follow-Up Study
- (2014) Jana Svatoňová et al. DISEASE MARKERS
- The granin VGF promotes genesis of secretory vesicles, and regulates circulating catecholamine levels and blood pressure
- (2014) Samira Fargali et al. FASEB JOURNAL
- An Integrated Workflow for Multiplex CSF Proteomics and Peptidomics—Identification of Candidate Cerebrospinal Fluid Biomarkers of Alzheimer’s Disease
- (2014) Mikko Hölttä et al. JOURNAL OF PROTEOME RESEARCH
- Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria
- (2014) Bruno Dubois et al. LANCET NEUROLOGY
- Targeting Synaptic Pathology with a Novel Affinity Mass Spectrometry Approach
- (2014) Ann Brinkmalm et al. MOLECULAR & CELLULAR PROTEOMICS
- The amyloid-β degradation pattern in plasma—A possible tool for clinical trials in Alzheimer's disease
- (2014) Josef Pannee et al. NEUROSCIENCE LETTERS
- Two Phase 3 Trials of Bapineuzumab in Mild-to-Moderate Alzheimer's Disease
- (2014) Stephen Salloway et al. NEW ENGLAND JOURNAL OF MEDICINE
- Oxidative stress and mitochondrial dysfunction in Alzheimer's disease
- (2013) Xinglong Wang et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Soluble amyloid precursor protein α and β in CSF in Alzheimer's disease
- (2013) Gunnar Brinkmalm et al. BRAIN RESEARCH
- Technical considerations for large-scale parallel reaction monitoring analysis
- (2013) Sebastien Gallien et al. Journal of Proteomics
- A role for the neurexin–neuroligin complex in Alzheimer's disease
- (2013) Ikhlas A. Sindi et al. NEUROBIOLOGY OF AGING
- CSF protein biomarkers predicting longitudinal reduction of CSF β-amyloid42 in cognitively healthy elders
- (2013) N Mattsson et al. Translational Psychiatry
- Neurofascin: A switch between neuronal plasticity and stability
- (2012) Martin Kriebel et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Targeted Proteomic Quantification on Quadrupole-Orbitrap Mass Spectrometer
- (2012) Sebastien Gallien et al. MOLECULAR & CELLULAR PROTEOMICS
- Parallel Reaction Monitoring for High Resolution and High Mass Accuracy Quantitative, Targeted Proteomics
- (2012) Amelia C. Peterson et al. MOLECULAR & CELLULAR PROTEOMICS
- Pentraxins and Alzheimer's disease: At the interface between biomarkers and pharmacological targets
- (2011) Cecilia Osera et al. AGEING RESEARCH REVIEWS
- The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease
- (2011) Guy M. McKhann et al. Alzheimers & Dementia
- The Extended Granin Family: Structure, Function, and Biomedical Implications
- (2011) Alessandro Bartolomucci et al. ENDOCRINE REVIEWS
- Chromogranin peptides in brain diseases
- (2011) Michael Willis et al. JOURNAL OF NEURAL TRANSMISSION
- CSF soluble amyloid precursor proteins in the diagnosis of incipient Alzheimer disease
- (2011) R. Perneczky et al. NEUROLOGY
- A Critical Role for Neurofascin in Regulating Action Potential Initiation through Maintenance of the Axon Initial Segment
- (2011) Barbara Zonta et al. NEURON
- Identification and Validation of Novel Cerebrospinal Fluid Biomarkers for Staging Early Alzheimer's Disease
- (2011) Richard J. Perrin et al. PLoS One
- Peptide Fingerprinting of Alzheimer's Disease in Cerebrospinal Fluid: Identification and Prospective Evaluation of New Synaptic Biomarkers
- (2011) Holger Jahn et al. PLoS One
- APP processing in Alzheimer's disease
- (2011) Yun-wu Zhang et al. Molecular Brain
- Processing of the Synaptic Cell Adhesion Molecule Neurexin-3β by Alzheimer Disease α- and γ-Secretases
- (2010) Nathalie Bot et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Cerebrospinal fluid and plasma biomarkers in Alzheimer disease
- (2010) Kaj Blennow et al. Nature Reviews Neurology
- Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects
- (2009) Leslie M. Shaw et al. ANNALS OF NEUROLOGY
- Clinical proteomics in neurodegenerative disorders
- (2008) H. Zetterberg et al. ACTA NEUROLOGICA SCANDINAVICA
- Elevated Cerebrospinal Fluid BACE1 Activity in Incipient Alzheimer Disease
- (2008) Henrik Zetterberg et al. ARCHIVES OF NEUROLOGY
- Serum cystatin C and the risk of Alzheimer disease in elderly men
- (2008) J. Sundelof et al. NEUROLOGY
- Cystatin C-Cathepsin B Axis Regulates Amyloid Beta Levels and Associated Neuronal Deficits in an Animal Model of Alzheimer's Disease
- (2008) Binggui Sun et al. NEURON
- Identification of a novel panel of cerebrospinal fluid biomarkers for Alzheimer's disease
- (2007) A.H. Simonsen et al. NEUROBIOLOGY OF AGING
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started